⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Iron dextran

آیرون دکستران

⚠ Unverified

🩸 Blood And Blood Forming OrgansParenteral iron

🤰 Pregnancy:Use with caution 👶 Children:Use with caution 🇮🇷 Not found in Iran list ⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA017441 ATC B03AC

Market / country: 🇺🇸 USA

INFeD (US)

🧮 Dose calculator

Disease / regimen

Iron-deficiency anaemia · Regimen source: FDA INFeD · 2.2 FDA INFeD · 2.4 FDA INFeD · 2.1

⛔ Adults and children >15 kg: volume (mL) = 0.0442 × (target Hb − observed Hb) × lean body weight + 0.26 × LBW (target 14.8). 5–15 kg: actual weight and target 12. Give a 0.5 mL test dose first and wait 1 h; max daily 2 mL (100 mg); rate max 50 mg/min. FDA INFeD · 2.2 FDA INFeD · 2.4 FDA INFeD · 2.1

🛡️ Safety & information

Contraindications

⛔ Previous hypersensitivity to iron dextran. FDA INFeD · 4

Warnings

• Boxed warning: fatal anaphylactic-type reactions — test dose before the first therapeutic dose, resuscitation equipment at hand. FDA INFeD · Boxed Warning
• Delayed reactions (arthralgia, myalgia, fever) 1–2 days later; iron overload. FDA INFeD · 5

Formulations

50 mg/mL, 2 mL vial (IV or IM) — injection 🇺🇸 USA FDA INFeD · 3

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA INFeD · 8.1
“Risk Summary Parenteral iron administration may be associated with hypersensitivity reactions [see Warnings and Precautions ( 5.1 )] , which may have serious consequences, such as fetal bradycardia (see Clinical Considerations).”
🤱 BreastfeedingNo data
The source for this drug has no section for this group.
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA INFeD · 8.4
“INFeD is not recommended for use in infants under 4 months of age [s ee Dosage and Administration ( 2.2 ) ].”
👴 Older adultsNo data
The source for this drug has no section for this group.
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)NDA017441
DailyMed (FDA label)FDA INFeD
MedlinePlus (NIH)Iron Dextran Injection
WHO ATC/DDDB03AC
Darooyab (Iran)Iron-Dextran

🇮🇷 Not found in Iran list Darooyab · G-2895/Iron-Dextran

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA INFeD · 3 FDA INFeD · 2.2 FDA INFeD · 2.4 FDA INFeD · 2.1 FDA INFeD · 4 FDA INFeD · Boxed Warning FDA INFeD · 5 FDA INFeD · 8.1 FDA INFeD · 8.4 FDA INFeD · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-2895/Iron-Dextran
Clinical review⚠ Unverified